International Society for the Study of Women's Sexual Health

NEWS

Flibanserin recommended for approval by the FDA Advisory Committee Panel

Dear ISSWSH members,
It is with great excitement that I share the announcement that flibanserin, a drug for hypoactive sexual desire disorder (HSDD) developed by Sprout Pharmaceuticals, was recommended for approval by the FDA Advisory Committee Panel on June 4, 2015.

This event opens the door for the first treatment for women suffering from HSDD, but more importantly sends the message that the FDA is now willing to entertain new drug applications from other companies. We are optimistic that this occurrence will instigate more research and eventually other therapeutic options. We also offer deep gratitude to many of our members who played a key role in this decision by voting as members of the FDA Advisory Panel, speaking as presenters on behalf of the sponsor, providing testimony during the Open Public Hearing, and caring for patients who also spoke at the Hearing.  

As a multidisciplinary, scientific organization dedicated to research, clinical practice, and education, we are poised to develop and disseminate clinical practice guidelines regarding screening, diagnosis, and management strategies. Through our robust infrastructure of educational programs, we will ensure appropriate, safe, and selective treatment of HSDD with flibanserin when final approval comes.

Most sincerely,
Sharon J. Parish, MD, IF
ISSWSH President, 2014-2016

Save the Date

ISSWSH Fall Course 2018
November 15-17, 2018   114 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH / ISSM Joint Meeting 2019
March 7-10, 2019   226 days left
Atlanta, GA, USA

Latest Tweets

Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource https://t.co/Q043F2YJOm. Encourag… https://t.co/6vDWxSzXvL ISSWSH
Pelvic exam is essential to the accurate diagnosis and treatment of #FSD, but it has a complicated history https://t.co/YTOy3eSbtJ ISSWSH
Check out these great books focusing on women's sexuality and #sexualhealth @ISSWSH https://t.co/gh0S07A5uk ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.